GLS and hepatocellular carcinoma: The importance of glutamine catabolism in MYC-driven HCC was further demonstrated by Xiang et al. who demonstrated that genetic ablation of one copy of Gls1 or treatment with two different inhibitors of Gls1 could significantly prolong survival in this same model (Xiang et al., 2015).